Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

NRx Pharmaceuticals (NRXPW) Competitors

NRx Pharmaceuticals logo
$0.0063 0.00 (-26.47%)
As of 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NRXPW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you buy NRx Pharmaceuticals stock or one of its competitors? MarketBeat compares NRx Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NRx Pharmaceuticals include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does NRx Pharmaceuticals compare to Ainos?

Ainos (NASDAQ:AIMDW) and NRx Pharmaceuticals (NASDAQ:NRXPW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
NRx Pharmaceuticals N/A N/A N/A

In the previous week, Ainos had 1 more articles in the media than NRx Pharmaceuticals. MarketBeat recorded 1 mentions for Ainos and 0 mentions for NRx Pharmaceuticals. Ainos' average media sentiment score of 0.00 equaled NRx Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Ainos Neutral
NRx Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
NRx Pharmaceuticals$1.23MN/AN/AN/AN/A

Summary

Ainos and NRx Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

How does NRx Pharmaceuticals compare to Alvotech?

NRx Pharmaceuticals (NASDAQ:NRXPW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

In the previous week, NRx Pharmaceuticals' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
NRx Pharmaceuticals Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
NRx PharmaceuticalsN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NRx Pharmaceuticals$1.23MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Summary

Alvotech beats NRx Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does NRx Pharmaceuticals compare to Aravive?

Aravive (NASDAQ:ARAV) and NRx Pharmaceuticals (NASDAQ:NRXPW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Aravive's average media sentiment score of 0.00 equaled NRx Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Aravive Neutral
NRx Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
NRx Pharmaceuticals N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
NRx Pharmaceuticals$1.23MN/AN/AN/AN/A

Summary

Aravive beats NRx Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does NRx Pharmaceuticals compare to Atlantic Coastal Acquisition Corp. II?

NRx Pharmaceuticals (NASDAQ:NRXPW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NRx Pharmaceuticals$1.23MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, NRx Pharmaceuticals' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
NRx Pharmaceuticals Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
NRx PharmaceuticalsN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

NRx Pharmaceuticals beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does NRx Pharmaceuticals compare to Avidity Biosciences?

NRx Pharmaceuticals (NASDAQ:NRXPW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

In the previous week, Avidity Biosciences had 5 more articles in the media than NRx Pharmaceuticals. MarketBeat recorded 5 mentions for Avidity Biosciences and 0 mentions for NRx Pharmaceuticals. Avidity Biosciences' average media sentiment score of 0.80 beat NRx Pharmaceuticals' score of 0.00 indicating that Avidity Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
NRx Pharmaceuticals Neutral
Avidity Biosciences Positive

Avidity Biosciences has a consensus price target of $69.42, indicating a potential upside of 436.07%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Avidity Biosciences is more favorable than NRx Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NRx Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.37

NRx Pharmaceuticals has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. NRx Pharmaceuticals' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
NRx PharmaceuticalsN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

NRx Pharmaceuticals has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NRx Pharmaceuticals$1.23MN/AN/AN/AN/A
Avidity Biosciences$36.68M6.04-$322.30MN/AN/A

Summary

Avidity Biosciences beats NRx Pharmaceuticals on 7 of the 10 factors compared between the two stocks.

Get NRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXPW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRXPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXPW vs. The Competition

MetricNRx PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$465.73M$6.25B$12.23B
Dividend YieldN/A3.87%2.80%5.32%
P/E RatioN/A3.7620.7925.05
Price / SalesN/A7,435.94531.2172.69
Price / CashN/A13.1343.0954.25
Price / BookN/A83.539.816.83
Net IncomeN/A-$96.07M$3.55B$335.69M
7 Day PerformanceN/A0.52%-2.07%-2.03%
1 Month PerformanceN/A0.18%-3.90%-1.90%
1 Year PerformanceN/A71.17%29.39%27.36%

NRx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRXPW
NRx Pharmaceuticals
N/A$0.01
-12.9%
N/A-88.7%$0.00$1.23MN/AN/A
AIMDW
Ainos
N/A$0.10
+1.8%
N/A-54.3%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.25
-3.8%
N/A-87.9%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:NRXPW) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners